Literature DB >> 22480210

Plasma membrane calcium ATPase expression in human colon multistep carcinogenesis.

Jan H Rüschoff1, Timo Brandenburger, Emanuel E Strehler, Adelaida G Filoteo, Ernst Heinmöller, Gerhard Aumüller, Beate Wilhelm.   

Abstract

The expression of the plasma membrane Ca(2+) ATPase (PMCA) was analyzed in a series of 84 formalin-fixed and paraffin embedded colon samples including normal mucosa (n = 32), adenoma (n = 19), adenocarcinoma (n = 27), and lymph node metastasis (n = 6) using (i) immunohistochemistry, (ii) mRNA in situ hybridization, and (iii) quantitative reverse-transcriptase PCR. A marked reduction of PMCA4 protein was observed in high-grade adenoma, colon cancer as well as lymph node metastasis, pointing to its potential role in the progression of cancer. However, PMCA4 RNA transcripts were unchanged or even increased in colon carcinomas, suggesting posttranscriptional regulation of PMCA4 during carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22480210     DOI: 10.3109/07357907.2012.657817

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  10 in total

Review 1.  Plasma membrane calcium ATPases as novel candidates for therapeutic agent development.

Authors:  Emanuel E Strehler
Journal:  J Pharm Pharm Sci       Date:  2013       Impact factor: 2.327

Review 2.  The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.

Authors:  Gaetano Romano
Journal:  Scientifica (Cairo)       Date:  2013-12-05

3.  Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK.

Authors:  Luca Hegedüs; Rita Padányi; Judit Molnár; Katalin Pászty; Karolina Varga; István Kenessey; Eszter Sárközy; Matthias Wolf; Michael Grusch; Zoltán Hegyi; László Homolya; Clemens Aigner; Tamás Garay; Balázs Hegedüs; József Tímár; Enikö Kállay; Ágnes Enyedi
Journal:  Front Oncol       Date:  2017-05-24       Impact factor: 6.244

Review 4.  A Comprehensive Review of Calcium Electroporation -A Novel Cancer Treatment Modality.

Authors:  Stine K Frandsen; Mille Vissing; Julie Gehl
Journal:  Cancers (Basel)       Date:  2020-01-25       Impact factor: 6.639

5.  The effect of iron on the expression levels of calcium related gene in cisplatin resistant epithelial ovarian cancer cells.

Authors:  Bahire Kucukkaya; Demet Erdag; Fahri Akbas; Leman Yalcintepe
Journal:  Explor Target Antitumor Ther       Date:  2021-08-30

Review 6.  Novel Biomarkers and Therapeutic Targets for Melanoma.

Authors:  Noa Sabag; Alexander Yakobson; Meir Retchkiman; Eldad Silberstein
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

7.  Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells.

Authors:  Karolina Varga; Anna Hollósi; Katalin Pászty; Luca Hegedűs; Gergely Szakács; József Tímár; Béla Papp; Ágnes Enyedi; Rita Padányi
Journal:  BMC Cancer       Date:  2018-10-23       Impact factor: 4.430

8.  P38 MAPK Promotes Migration and Metastatic Activity of BRAF Mutant Melanoma Cells by Inducing Degradation of PMCA4b.

Authors:  Randa Naffa; Lisa Vogel; Luca Hegedűs; Katalin Pászty; Sarolta Tóth; Kornélia Kelemen; Neha Singh; Attila Reményi; Enikő Kállay; Mihály Cserepes; József Tóvári; Michael Grusch; Ágnes Enyedi
Journal:  Cells       Date:  2020-05-13       Impact factor: 6.600

Review 9.  Various Aspects of Calcium Signaling in the Regulation of Apoptosis, Autophagy, Cell Proliferation, and Cancer.

Authors:  Simone Patergnani; Alberto Danese; Esmaa Bouhamida; Gianluca Aguiari; Maurizio Previati; Paolo Pinton; Carlotta Giorgi
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

10.  The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition.

Authors:  Luca Hegedüs; Elisabeth Livingstone; Ágnes Bánkfalvi; Jan Viehof; Ágnes Enyedi; Ágnes Bilecz; Balázs Győrffy; Marcell Baranyi; Anna-Mária Tőkés; Jeovanis Gil; György Marko-Varga; Klaus G Griewank; Lisa Zimmer; Renáta Váraljai; Antje Sucker; Anne Zaremba; Dirk Schadendorf; Clemens Aigner; Balázs Hegedüs
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.